Drug information for FERRIPROX

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 500MG Prescription  (Reference Drug) DEFERIPRONE deferiprone APOPHARMA INC 21825
2012-04-24 Label
2012-04-24 Letter
2011-12-02 Summary Review
2011-11-30 Review
2011-10-14 Label
2011-10-14 Letter

Drug Adverse Effects information for FERRIPROX

Role code Indications Reaction # Reports
C BONE MARROW TRANSPLANT FIBROSIS 2
C BONE MARROW TRANSPLANT HEPATIC CIRRHOSIS 4
C BONE MARROW TRANSPLANT SERUM FERRITIN ABNORMAL 2
C BONE MARROW TRANSPLANT SERUM FERRITIN INCREASED 2
C THALASSAEMIA BETA FIBROSIS 1
C THALASSAEMIA BETA HEPATIC CIRRHOSIS 2
C THALASSAEMIA BETA SERUM FERRITIN ABNORMAL 1
C THALASSAEMIA BETA SERUM FERRITIN INCREASED 1
Ads by Google